• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    Alkermes plc (ALKS)

    -NasdaqGS
    63.84 Up 0.77(1.22%) 4:00PM EDT
    |After Hours : 63.57 Down 0.27 (0.43%) 4:12PM EDT
    Add to Portfolio
    Prev Close:63.07
    Open:62.69
    Bid:63.72 x 100
    Ask:67.00 x 100
    1y Target Est:70.82
    Beta:1.31
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:62.07 - 64.98
    52wk Range:38.49 - 75.17
    Volume:715,102
    Avg Vol (3m):1,117,490
    Market Cap:9.49B
    P/E (ttm):N/A
    EPS (ttm):-0.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALKS

    Comparison

    Symbol% ChgMkt Cap
    ALKSUp 1.22%9.49B
    ABTUp 0.67%74.05B
    LLYUp 0.24%91.44B
    GSKDown 0.73%101.31B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.44
    Quarterly EPS Est (Jun-15) :-0.08
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-4.27

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback